Hanna Gyllensten

1.7k total citations
80 papers, 1.1k citations indexed

About

Hanna Gyllensten is a scholar working on Economics and Econometrics, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hanna Gyllensten has authored 80 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 20 papers in Pathology and Forensic Medicine and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hanna Gyllensten's work include Multiple Sclerosis Research Studies (20 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Pharmaceutical Practices and Patient Outcomes (16 papers). Hanna Gyllensten is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Pharmaceutical Practices and Patient Outcomes (16 papers). Hanna Gyllensten collaborates with scholars based in Sweden, South Africa and Belgium. Hanna Gyllensten's co-authors include Kristina Alexanderson, Anna K. Jönsson, Max Petzold, Staffan Hägg, Katja M. Hakkarainen, Petter Tinghög, Emilie Friberg, Jan Hillert, Khedidja Hedna and Inger Ekman and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Pain.

In The Last Decade

Hanna Gyllensten

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanna Gyllensten Sweden	19	313	276	244	224	151	80	1.1k
Gemma Spiers United Kingdom	18	67 0.2×	343 1.2×	219 0.9×	319 1.4×	165 1.1×	50	1.2k
Marion Schaefer Germany	16	40 0.1×	407 1.5×	94 0.4×	154 0.7×	198 1.3×	53	1.0k
Kathleen A. Fairman United States	15	52 0.2×	172 0.6×	314 1.3×	93 0.4×	132 0.9×	56	963
Elayne Livote United States	18	136 0.4×	91 0.3×	93 0.4×	186 0.8×	148 1.0×	27	1.2k
Gabriel Sanfélix‐Gimeno Spain	24	57 0.2×	152 0.6×	217 0.9×	146 0.7×	127 0.8×	92	1.6k
Kavita V. Nair United States	16	56 0.2×	142 0.5×	201 0.8×	118 0.5×	63 0.4×	69	891
Christopher M. Burkle United States	20	54 0.2×	128 0.5×	84 0.3×	243 1.1×	174 1.2×	62	1.5k
Carolyn Czoski‐Murray United Kingdom	17	50 0.2×	103 0.4×	330 1.4×	201 0.9×	59 0.4×	38	1.2k
Frank Verheyen Germany	16	56 0.2×	92 0.3×	149 0.6×	199 0.9×	91 0.6×	53	1.2k
Derjung M. Tarn United States	22	21 0.1×	369 1.3×	220 0.9×	612 2.7×	230 1.5×	73	1.6k

Countries citing papers authored by Hanna Gyllensten

Since Specialization

Citations

This map shows the geographic impact of Hanna Gyllensten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Gyllensten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Gyllensten more than expected).

Fields of papers citing papers by Hanna Gyllensten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Gyllensten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Gyllensten. The network helps show where Hanna Gyllensten may publish in the future.

Co-authorship network of co-authors of Hanna Gyllensten

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Gyllensten. A scholar is included among the top collaborators of Hanna Gyllensten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Gyllensten. Hanna Gyllensten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gyllensten, Hanna, et al.. (2025). Person-Centred Care: State-of-the-Art and Future Perspectives. Current Heart Failure Reports. 22(1). 15–15.

Ekman, Inger, et al.. (2025). Patient and healthcare professional engagement and time use within a randomised controlled trial: investigating intervention costs associated with remote person-centred care in Sweden. BMJ Open. 15(10). e099034–e099034.

Teni, Fitsum Sebsibe, et al.. (2025). Factors associated with self-reported work ability among people with multiple sclerosis in Sweden. Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(1). 3110667524–3110667524.

Teni, Fitsum Sebsibe, Alejandra Machado, Katharina Fink, et al.. (2024). Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in Sweden. Multiple Sclerosis Journal. 30(3). 419–431. 1 indexed citations

Tistad, Malin, et al.. (2023). Implementing a new birthing room design: a qualitative study with a care provider perspective. BMC Health Services Research. 23(1). 1122–1122.

Teni, Fitsum Sebsibe, Alejandra Machado, Katharina Fink, et al.. (2023). Self‐reported restrictions in different life domains and associated factors among people with multiple sclerosis in Sweden. European Journal of Neurology. 30(7). 1843–1853. 3 indexed citations

Karampampa, Korinna, Hanna Gyllensten, Emilie Friberg, et al.. (2023). Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab. BMJ Open. 13(5). e067516–e067516. 1 indexed citations

Hedna, Khedidja, et al.. (2022). Healthcare costs of adverse drug reactions and potentially inappropriate prescribing in older adults: a population-based study. BMJ Open. 12(9). e062589–e062589. 11 indexed citations

Gyllensten, Hanna, Cecily Begley, Christina Nilsson, et al.. (2022). Impact of Birthing Room Design on Maternal Childbirth Experience: Results From the Room4Birth Randomized Trial. HERD Health Environments Research & Design Journal. 16(1). 200–218. 7 indexed citations

10.

Teni, Fitsum Sebsibe, Alejandra Machado, Anna He, et al.. (2022). Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden. Multiple Sclerosis and Related Disorders. 69. 104456–104456. 2 indexed citations

11.

Löfqvist, Chatarina, et al.. (2021). Systematic review of the healthcare cost of bronchopulmonary dysplasia. BMJ Open. 11(8). e045729–e045729. 22 indexed citations

12.

Gyllensten, Hanna, Ida Björkman, Eva Jakobsson Ung, Inger Ekman, & Sofie Jakobsson. (2020). A national research centre for the evaluation and implementation of person‐centred care: Content from the first interventional studies. Health Expectations. 23(5). 1362–1375. 24 indexed citations

13.

Ali, Lilas, Sara Wallström, Andreas Fors, et al.. (2020). Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled trial. BMJ Open. 10(7). e036356–e036356. 10 indexed citations

14.

Lalic, Samanta, J. Simon Bell, Hanna Gyllensten, et al.. (2019). Trajectories of sickness absence and disability pension before and after opioid initiation for noncancer pain: a 10-year population-based study. Pain. 160(5). 1224–1233. 9 indexed citations

15.

Berg, Marie, Christina Nilsson, Helle Wijk, et al.. (2019). Room4Birth - the effect of an adaptable birthing room on labour and birth outcomes for nulliparous women at term with spontaneous labour start: study protocol for a randomised controlled superiority trial in Sweden. Trials. 20(1). 629–629. 13 indexed citations

16.

Wallström, Sara, Inger Ekman, Elmir Ömerovic, Kerstin Ulin, & Hanna Gyllensten. (2019). Cohort study of healthcare use, costs and diagnoses from onset to 6 months after discharge for takotsubo syndrome in Sweden. BMJ Open. 9(2). e027814–e027814. 5 indexed citations

17.

Brämberg, Elisabeth Björk, Kristina Holmgren, Ute Bültmann, et al.. (2018). Increasing return-to-work among people on sick leave due to common mental disorders: design of a cluster-randomized controlled trial of a problem-solving intervention versus care-as-usual conducted in the Swedish primary health care system (PROSA). BMC Public Health. 18(1). 889–889. 24 indexed citations

18.

Gyllensten, Hanna, Andrius Kavaliūnas, Jan Hillert, et al.. (2017). Costs of Illness Progression for Different Multiple Sclerosis Phenotypes: A Population-Based Study in Sweden. Value in Health. 20(9). A407–A407. 1 indexed citations

19.

Gyllensten, Hanna, Anna K. Jönsson, Katja M. Hakkarainen, et al.. (2017). Comparing Methods for Estimating Direct Costs of Adverse Drug Events. Value in Health. 20(10). 1299–1310. 6 indexed citations

20.

Gyllensten, Hanna, et al.. (2016). How does work disability of patients with MS develop before and after diagnosis? A nationwide cohort study with a reference group. BMJ Open. 6(11). e012731–e012731. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact